XML 255 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement - Restatements (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Current assets:          
Cash and cash equivalents $ 204,126 $ 247,504 $ 189,082    
Accounts receivable, net of allowances of $3,633 15,766 13,389 13,177    
Allowance for credit loss 4,870 3,633 4,730   $ 4,060
Prepaid expenses and other current assets 19,581 22,930 16,699    
Total current assets 262,195 283,823 241,680    
Property and equipment, net 34,446 47,769 30,823    
Goodwill 63,247 59,994 63,229    
Intangible assets, net 17,566 15,361 18,900    
Operating lease right-of-use assets 10,461 5,292 11,148 $ 5,700  
Deferred income taxes 26,682 28,726 29,380    
Available-for-sale debt securities 1,000 1,182 995    
Other assets 8,755 13,157 9,240    
Total assets 424,352 455,304 405,395    
Current liabilities:          
Accounts payable 25,803 31,747 25,312    
Accrued expenses and other current liabilities 51,682 56,606 57,373    
Deferred revenue 181,219 163,016 164,200    
Operating lease liabilities 2,351 1,607 2,317    
Total current liabilities 261,055 252,976 249,202    
Operating lease liabilities, non-current 8,353 3,505 8,958    
Deferred revenue 794 1,283 892    
Other liabilities 4,133 2,833 3,968    
Total liabilities 274,335 260,597 263,020    
Stockholders’ equity:          
Preferred stock, $0.001 par value; 100,000 shares authorized at March 31, 2023 and December 31, 2022, none issued or outstanding at March 31, 2023 and December 31, 2022 $ 0 $ 0 $ 0    
Preferred stock par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001    
Preferred stock shares authorized (in shares) 100,000,000 100,000 100,000,000    
Preferred stock shares issued (in shares) 0 0 0    
Preferred stock shares outstanding (in shares) 0 0 0    
Common stock, $0.001 par value; 1,000,000 shares authorized; 191,244 shares and 190,822 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively $ 190 $ 198 $ 190    
Common stock par value (in dollars per share) $ 0.001 $ 0.001 $ 0.001    
Common stock shares authorized (in shares) 1,000,000,000 1,000,000 1,000,000,000    
Common stock shares issued (in shares) 191,244,000 198,599 190,822,000    
Common stock shares outstanding (in shares) 191,244,000 198,599 190,822,000    
Additional paid-in capital $ 1,049,948 $ 969,731 $ 1,032,550    
Accumulated deficit (900,987) (774,867) (891,862)    
Accumulated other comprehensive income 866 (355) 1,497    
Total stockholders’ equity 150,017 194,707 142,375   197,551
Total liabilities and stockholders’ equity 424,352 455,304 405,395    
Income Statement [Abstract]          
Revenue 165,936 155,427      
Cost of revenue 60,395 56,182      
Gross profit 105,541 99,245      
Operating expenses:          
Sales and marketing 60,150 76,874      
Technology and development 19,683 17,959      
General and administrative 26,504 29,488      
Total operating expenses 106,337 124,321      
Loss from operations (796) (25,076)      
Interest income (expense), net 1,581 (53)      
Other income (expense), net 694 (1,544)      
Income (loss) before income taxes 1,479 (26,673)      
Provision for (benefit from) income taxes 3,837 (920)      
Net loss $ (2,358) $ (25,753)      
Net loss per share attributable to common stockholders—basic (in dollars per share) $ (0.01) $ (0.13)      
Net loss per share attributable to common stockholders—diluted (in dollar per share) $ (0.01) $ (0.13)      
Weighted-average shares used to compute net loss per share attributable to common stockholders—basic (in shares) 191,293,000 198,265,000      
Weighted-average shares used to compute net loss per share attributable to common stockholders—diluted (in shares) 191,293,000 198,265,000      
Statement of Other Comprehensive Income [Abstract]          
Net loss $ (2,358) $ (25,753)      
Other comprehensive income (631) 1,440      
Total comprehensive loss (2,989) (24,313)      
Statement of Stockholders' Equity [Abstract]          
Beginning balance 142,375 197,551      
Net loss (2,358) (25,753)      
Ending balance 150,017 194,707      
Cash flows from operating activities          
Net loss (2,358) (25,753)      
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation and amortization 5,569 5,394      
Amortization of right-of-use assets 687 378      
Amortization of debt issuance costs 56 56      
Impairment of other equity security 0 170      
Stock-based compensation 16,467 21,865      
Deferred income taxes 2,763 (1,086)      
Unrealized foreign exchange (gain) loss (579) 1,379      
Changes in operating assets and liabilities:          
Accounts receivable (2,588) (2,755)      
Prepaid expenses and other current assets (2,869) (6,464)      
Other assets 348 (811)      
Accounts payable 936 (117)      
Accrued expenses and other liabilities (4,947) 5,772      
Operating lease liabilities (572) (770)      
Income tax payable 7 7      
Deferred revenue 16,918 16,472      
Net cash provided by operating activities 29,208 13,737      
Cash flows from investing activities          
Proceeds from acquisition working capital adjustment 0 304      
Purchase of property and equipment (7,428) (4,911)      
Net cash used in investing activities (7,428) (4,607)      
Cash flows from financing activities          
Repayment of capital lease obligations (9) (4)      
Repurchase and retirement of common stock (6,768) (1,094)      
Shares surrendered for settlement of minimum statutory tax withholding 0 (11)      
Proceeds from issuance of stock under employee stock plans 22 237      
Net cash used in financing activities (6,755) (872)      
Effect of exchange rate changes on cash and cash equivalents 19 (51)      
Net increase in cash and cash equivalents 15,044 8,207      
Cash and cash equivalents, at beginning of the period 189,082 239,297      
Cash and cash equivalents, at end of the period 204,126 247,504      
Common Stock          
Stockholders’ equity:          
Total stockholders’ equity $ 190 $ 198 190   198
Statement of Stockholders' Equity [Abstract]          
Beginning balance, shares 190,822,000 198,084,000      
Beginning balance $ 190 $ 198      
Ending balance, shares 191,244,000 198,599,000      
Ending balance $ 190 $ 198      
Additional Paid-In Capital          
Stockholders’ equity:          
Total stockholders’ equity 1,049,948 969,731 1,032,550   947,160
Statement of Stockholders' Equity [Abstract]          
Beginning balance 1,032,550 947,160      
Ending balance 1,049,948 969,731      
Accumulated Deficit          
Stockholders’ equity:          
Total stockholders’ equity (900,987) (774,867) (891,862)   (748,012)
Operating expenses:          
Net loss (2,358) (25,753)      
Statement of Other Comprehensive Income [Abstract]          
Net loss (2,358) (25,753)      
Statement of Stockholders' Equity [Abstract]          
Beginning balance (891,862) (748,012)      
Net loss (2,358) (25,753)      
Ending balance (900,987) (774,867)      
Cash flows from operating activities          
Net loss (2,358) (25,753)      
Accumulated Other Comprehensive (Loss) Income          
Stockholders’ equity:          
Accumulated other comprehensive income 866 (355) 1,497   (1,795)
Total stockholders’ equity 866 (355) $ 1,497   $ (1,795)
Statement of Other Comprehensive Income [Abstract]          
Other comprehensive income (631) 1,440      
Statement of Stockholders' Equity [Abstract]          
Beginning balance 1,497 (1,795)      
Ending balance 866 (355)      
As Reported          
Current assets:          
Cash and cash equivalents   247,504      
Accounts receivable, net of allowances of $3,633   12,784      
Allowance for credit loss $ 3,633        
Prepaid expenses and other current assets   23,172      
Total current assets   283,460      
Property and equipment, net   47,769      
Goodwill   59,994      
Intangible assets, net   15,361      
Operating lease right-of-use assets   5,292      
Deferred income taxes   24,849      
Available-for-sale debt securities   1,182      
Other assets   13,157      
Total assets   451,064      
Current liabilities:          
Accounts payable   31,747      
Accrued expenses and other current liabilities   56,509      
Deferred revenue   163,729      
Operating lease liabilities   1,607      
Total current liabilities   253,592      
Operating lease liabilities, non-current   3,505      
Deferred revenue   1,283      
Other liabilities   2,833      
Total liabilities   261,213      
Stockholders’ equity:          
Preferred stock, $0.001 par value; 100,000 shares authorized at March 31, 2023 and December 31, 2022, none issued or outstanding at March 31, 2023 and December 31, 2022   0      
Common stock, $0.001 par value; 1,000,000 shares authorized; 191,244 shares and 190,822 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively   198      
Additional paid-in capital   969,731      
Accumulated deficit   (779,723)      
Accumulated other comprehensive income   (355)      
Total stockholders’ equity   189,851      
Total liabilities and stockholders’ equity   451,064      
Income Statement [Abstract]          
Revenue   154,209      
Cost of revenue   55,940      
Gross profit   98,269      
Operating expenses:          
Sales and marketing   76,874      
Technology and development   17,959      
General and administrative   29,488      
Total operating expenses   124,321      
Loss from operations   (26,052)      
Interest income (expense), net   (53)      
Other income (expense), net   (1,544)      
Income (loss) before income taxes   (27,649)      
Provision for (benefit from) income taxes   2,960      
Net loss   $ (30,609)      
Net loss per share attributable to common stockholders—basic (in dollars per share)   $ (0.15)      
Net loss per share attributable to common stockholders—diluted (in dollar per share)   $ (0.15)      
Weighted-average shares used to compute net loss per share attributable to common stockholders—basic (in shares)   198,265,000      
Weighted-average shares used to compute net loss per share attributable to common stockholders—diluted (in shares)   198,265,000      
Statement of Other Comprehensive Income [Abstract]          
Net loss   $ (30,609)      
Other comprehensive income   1,440      
Total comprehensive loss   (29,169)      
Statement of Stockholders' Equity [Abstract]          
Beginning balance          
Net loss   (30,609)      
Ending balance   189,851      
Cash flows from operating activities          
Net loss   (30,609)      
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation and amortization   5,394      
Amortization of right-of-use assets   378      
Amortization of debt issuance costs   56      
Impairment of other equity security   170      
Stock-based compensation   21,865      
Deferred income taxes   2,791      
Unrealized foreign exchange (gain) loss   1,379      
Changes in operating assets and liabilities:          
Accounts receivable   (2,150)      
Prepaid expenses and other current assets   (6,706)      
Other assets   (811)      
Accounts payable   (117)      
Accrued expenses and other liabilities   5,675      
Operating lease liabilities   (770)      
Income tax payable   7      
Deferred revenue   17,185      
Net cash provided by operating activities   13,737      
Cash flows from investing activities          
Proceeds from acquisition working capital adjustment   304      
Purchase of property and equipment   (4,911)      
Net cash used in investing activities   (4,607)      
Cash flows from financing activities          
Repayment of capital lease obligations   (4)      
Repurchase and retirement of common stock   (1,094)      
Shares surrendered for settlement of minimum statutory tax withholding   (11)      
Proceeds from issuance of stock under employee stock plans   237      
Net cash used in financing activities   (872)      
Effect of exchange rate changes on cash and cash equivalents   (51)      
Net increase in cash and cash equivalents   8,207      
Cash and cash equivalents, at beginning of the period   239,297      
Cash and cash equivalents, at end of the period   247,504      
As Reported | Common Stock          
Stockholders’ equity:          
Total stockholders’ equity   $ 198      
Statement of Stockholders' Equity [Abstract]          
Beginning balance, shares          
Beginning balance          
Ending balance, shares   198,599,000      
Ending balance   $ 198      
As Reported | Additional Paid-In Capital          
Stockholders’ equity:          
Total stockholders’ equity   969,731      
Statement of Stockholders' Equity [Abstract]          
Beginning balance          
Ending balance   969,731      
As Reported | Accumulated Deficit          
Stockholders’ equity:          
Total stockholders’ equity   (779,723)      
Statement of Stockholders' Equity [Abstract]          
Beginning balance          
Ending balance   (779,723)      
As Reported | Accumulated Other Comprehensive (Loss) Income          
Stockholders’ equity:          
Total stockholders’ equity   (355)      
Statement of Stockholders' Equity [Abstract]          
Beginning balance          
Ending balance   (355)      
Adjustments          
Current assets:          
Cash and cash equivalents   0      
Accounts receivable, net of allowances of $3,633   605      
Prepaid expenses and other current assets   (242)      
Total current assets   363      
Property and equipment, net   0      
Goodwill   0      
Intangible assets, net   0      
Operating lease right-of-use assets   0      
Deferred income taxes   3,877      
Available-for-sale debt securities   0      
Other assets   0      
Total assets   4,240      
Current liabilities:          
Accounts payable   0      
Accrued expenses and other current liabilities   97      
Deferred revenue   (713)      
Operating lease liabilities   0      
Total current liabilities   (616)      
Operating lease liabilities, non-current   0      
Deferred revenue   0      
Other liabilities   0      
Total liabilities   (616)      
Stockholders’ equity:          
Preferred stock, $0.001 par value; 100,000 shares authorized at March 31, 2023 and December 31, 2022, none issued or outstanding at March 31, 2023 and December 31, 2022   0      
Common stock, $0.001 par value; 1,000,000 shares authorized; 191,244 shares and 190,822 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively   0      
Additional paid-in capital   0      
Accumulated deficit   4,856      
Accumulated other comprehensive income   0      
Total stockholders’ equity   4,856      
Total liabilities and stockholders’ equity   4,240      
Income Statement [Abstract]          
Revenue   1,218      
Cost of revenue   242      
Gross profit   976      
Operating expenses:          
Sales and marketing   0      
Technology and development   0      
General and administrative   0      
Total operating expenses   0      
Loss from operations   976      
Interest income (expense), net   0      
Other income (expense), net   0      
Income (loss) before income taxes   976      
Provision for (benefit from) income taxes   (3,880)      
Net loss   $ 4,856      
Net loss per share attributable to common stockholders—basic (in dollars per share)   $ 0      
Net loss per share attributable to common stockholders—diluted (in dollar per share)   $ 0      
Weighted-average shares used to compute net loss per share attributable to common stockholders—basic (in shares)   0      
Weighted-average shares used to compute net loss per share attributable to common stockholders—diluted (in shares)   0      
Statement of Other Comprehensive Income [Abstract]          
Net loss   $ 4,856      
Other comprehensive income   0      
Total comprehensive loss   4,856      
Statement of Stockholders' Equity [Abstract]          
Beginning balance          
Net loss   4,856      
Ending balance   4,856      
Cash flows from operating activities          
Net loss   4,856      
Adjustments to reconcile net loss to net cash provided by operating activities:          
Depreciation and amortization   0      
Amortization of right-of-use assets   0      
Amortization of debt issuance costs   0      
Impairment of other equity security   0      
Stock-based compensation   0      
Deferred income taxes   (3,877)      
Unrealized foreign exchange (gain) loss   0      
Changes in operating assets and liabilities:          
Accounts receivable   (605)      
Prepaid expenses and other current assets   242      
Other assets   0      
Accounts payable   0      
Accrued expenses and other liabilities   97      
Operating lease liabilities   0      
Income tax payable   0      
Deferred revenue   (713)      
Net cash provided by operating activities   0      
Cash flows from investing activities          
Proceeds from acquisition working capital adjustment   0      
Purchase of property and equipment   0      
Net cash used in investing activities   0      
Cash flows from financing activities          
Repayment of capital lease obligations   0      
Repurchase and retirement of common stock   0      
Shares surrendered for settlement of minimum statutory tax withholding   0      
Proceeds from issuance of stock under employee stock plans   0      
Net cash used in financing activities   0      
Effect of exchange rate changes on cash and cash equivalents   0      
Net increase in cash and cash equivalents   0      
Cash and cash equivalents, at beginning of the period   0      
Cash and cash equivalents, at end of the period   $ 0